HORYZONS trial: protocol for a randomised controlled trial of a moderated online social therapy to maintain treatment effects from first-episode psychosis services

Alvarez-Jimenez, Mario, Bendall, Sarah, Koval, Peter, Rice, Simon, Cagliarini, Daniela, Valentine, Lee, D'Alfonso, Simon, Miles, Christopher, Russon, Penni, Penn, David L., Phillips, Jess, Lederman, Reeva, Wadley, Greg, Killackey, Eoin, Santesteban-Echarri, Olga, Mihalopoulos, Cathrine, Herrman, Helen, Gonzalez-Blanch, Cesar, Gilbertson, Tamsyn, Lal, Shalini, Chambers, Richard, Daglas-Georgiou, Rothanthi, Latorre, Cristina, Cotton, Sue M., McGorry, Patrick D. and Gleeson, John F. 2019, HORYZONS trial: protocol for a randomised controlled trial of a moderated online social therapy to maintain treatment effects from first-episode psychosis services, BMJ Open, vol. 9, no. 2, doi: 10.1136/bmjopen-2018-024104.

Attached Files
Name Description MIMEType Size Downloads

Title HORYZONS trial: protocol for a randomised controlled trial of a moderated online social therapy to maintain treatment effects from first-episode psychosis services
Author(s) Alvarez-Jimenez, Mario
Bendall, Sarah
Koval, Peter
Rice, Simon
Cagliarini, Daniela
Valentine, Lee
D'Alfonso, Simon
Miles, Christopher
Russon, Penni
Penn, David L.
Phillips, Jess
Lederman, Reeva
Wadley, Greg
Killackey, Eoin
Santesteban-Echarri, Olga
Mihalopoulos, CathrineORCID iD for Mihalopoulos, Cathrine orcid.org/0000-0002-7127-9462
Herrman, Helen
Gonzalez-Blanch, Cesar
Gilbertson, Tamsyn
Lal, Shalini
Chambers, Richard
Daglas-Georgiou, Rothanthi
Latorre, Cristina
Cotton, Sue M.
McGorry, Patrick D.
Gleeson, John F.
Journal name BMJ Open
Volume number 9
Issue number 2
Article ID e024104
Total pages 14
Publisher BMJ Open
Place of publication London, Eng.
Publication date 2019-02-19
ISSN 2044-6055
Keyword(s) mental health
psychiatry
Summary INTRODUCTION: Specialised early intervention services have demonstrated improved outcomes in first-episode psychosis (FEP); however, clinical gains may not be sustained after patients are transferred to regular care. Moreover, many patients with FEP remain socially isolated with poor functional outcomes. To address this, our multidisciplinary team has developed a moderated online social media therapy (HORYZONS) designed to enhance social functioning and maintain clinical gains from specialist FEP services. HORYZONS merges: (1) peer-to-peer social networking; (2) tailored therapeutic interventions; (3) expert and peer-moderation; and (4) new models of psychological therapy (strengths and mindfulness-based interventions) targeting social functioning. The aim of this trial is to determine whether following 2 years of specialised support and 18-month online social media-based intervention (HORYZONS) is superior to 18 months of regular care. METHODS AND ANALYSIS: This study is a single-blind randomised controlled trial. The treatment conditions include HORYZONS plus treatment as usual (TAU) or TAU alone. We recruited 170 young people with FEP, aged 16-27 years, in clinical remission and nearing discharge from Early Psychosis Prevention and Intervention Centre, Melbourne. The study includes four assessment time points, namely, baseline, 6-month, 12-month and 18-month follow-up. The study is due for completion in July 2018 and included a 40-month recruitment period and an 18-month treatment phase. The primary outcome is social functioning at 18 months. Secondary outcome measures include rate of hospital admissions, cost-effectiveness, vocational status, depression, social support, loneliness, self-esteem, self-efficacy, anxiety, psychological well-being, satisfaction with life, quality of life, positive and negative psychotic symptoms and substance use. Social functioning will be also assessed in real time through our Smartphone Ecological Momentary Assessment tool. ETHICS AND DISSEMINATION: Melbourne Health Human Research Ethics Committee (2013.146) provided ethics approval for this study. Findings will be made available through scientific journals and forums and to the public via social media and the Orygen website. TRIAL REGISTRATION NUMBER: ACTRN12614000009617; Pre-results.
Language eng
DOI 10.1136/bmjopen-2018-024104
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2019, The Authors
Persistent URL http://hdl.handle.net/10536/DRO/DU:30119024

Document type: Journal Article
Collections: School of Health and Social Development
Open Access Checking
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in TR Web of Science
Scopus Citation Count Cited 1 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 0 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Tue, 26 Feb 2019, 15:06:36 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.